Ciclosporin therapy is associated with minimal changes in calcium metabolism in dogs with atopic dermatitis

Veterinary Dermatology

Volumn 23, Issue 6, 2012, Pages

  Kovalik, Marcel ^a   Mellanby, Richard J ^a,b   Evans, Helen ^c   Berry, Jacqueline ^d   van den Broek, Adri H M ^a,b   Thoday, Keith L ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Cambridge Specialist Laboratory Services   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; CALCIUM; CYCLOSPORIN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PARATHYROID HORMONE; VITAMIN D;

ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; BLOOD; CLINICAL TRIAL; DOG; DOG DISEASE; DRUG EFFECT; FEMALE; HOMEOSTASIS; MALE; METABOLISM;

ANIMALS; CALCIUM; CYCLOSPORINE; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; FEMALE; HOMEOSTASIS; IMMUNOSUPPRESSIVE AGENTS; MALE; PARATHYROID HORMONE; VITAMIN D;

ANIMALIA; CANIS FAMILIARIS;

EID: 84869078865     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2012.01119.x     Document Type: Article

References (56)

1. Robson DC, Burton GG. Cyclosporin: applications in small animal dermatology. Vet Dermatol 2003; 14: 1-9.
2. Olivry T, Foster AP, Mueller RS et al. Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Vet Dermatol 2010; 21: 4-22.
3. Adamo FR, O'Brien RT. Use of cyclosporine to treat granulomatous meningoencephalitis in three dogs. J Am Vet Med Assoc 2004; 225: 1211-1216.
4. Doust R, Griffiths LG, Sullivan M. Evaluation of once daily treatment with cyclosporine for anal furunculosis in dogs. Vet Rec 2003; 152: 225-229.
5. Griffiths LG, Sullivan M, Borland WW. Cyclosporin as the sole treatment for anal furunculosis: preliminary results. J Small Anim Pract 1999; 40: 569-572.
6. Bexfield NH, Watson PJ, Herrtage ME. Management of myasthenia gravis using cyclosporine in 2 dogs. J Vet Intern Med 2006; 20: 1487-1490.
7. Lortz J, Favrot C, Mecklenburg L et al. A multicentre placebo-controlled clinical trial on the efficacy of oral ciclosporin A in the treatment of canine idiopathic sebaceous adenitis in comparison with conventional topical treatment. Vet Dermatol 2010; 21: 593-601.
8. Olivry T, Rivierre C, Murphy KM. Efficacy of cyclosporine for treatment induction of canine pemphigus foliaceus. Vet Rec 2003; 152: 53-54.
9. Guaguère E. Efficacy of cyclosporin in the treatment of idiopathic sterile nodular panniculitis in two dogs. Vet Dermatol 2000; 11(Suppl. 1): 22 (Abstract).
10. Kovalik M, Thoday KL, van den Broek AH. The use of ciclosporin A in veterinary dermatology. Vet J 2012; 193: 317-325.
11. Steffan J, Favrot C, Mueller R. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Vet Dermatol 2006; 17: 3-16.
12. Amor KT, Ryan C, Menter A. The use of cyclosporine in dermatology: part I. J Am Acad Dermatol 2010; 63: 925-946.
13. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725-1738.
14. Menter A, Korman NJ, Elmets CA et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 2009; 61: 451-485.
15. Hanifin JM, Cooper KD, Ho VC et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol 2004; 50: 391-404.
16. Grattan CE, Humphreys F. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 2007; 157: 1116-1123.
17. Gupta AK, Brown MD, Ellis CN et al. Cyclosporine in dermatology. J Am Acad Dermatol 1989; 21: 1245-1256.
18. Graziani G, Aroldi A, Castelnovo C et al. Ciclosporin and calcium metabolism in renal transplanted patients. Nephron 1991; 57: 479-480.
19. Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 1996; 11: 1-7.
20. Sheil AG. Cancer in immune-suppressed organ transplant recipients: aetiology and evolution. Trans Proc 1998; 30: 2055-2057.
21. Takai K, Aoki A, Suga A et al. Urinary tract infections following renal transplantation. Trans Proc 1998; 30: 3140-3141.
22. Sambrook PN. Cyclosporine and bone mass. Clin Exp Rheumatol 2000; 18: S93-S96.
23. Epstein S, Shane E, Bilezikian JP. Organ transplantation and osteoporosis. Curr Opin Rheumatol 1995; 7: 255-261.
24. Shane E, Epstein S. Transplantation osteoporosis. TransplantRev 2001; 15: 11.
25. Grotz WH, Mundinger FA, Gugel B et al. Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft recipients up to 20years after transplantation. Transplantation 1995; 59: 982-986.
26. Julian BA, Laskow DA, Dubovsky J et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544-550.
27. Torregrosa JV, Campistol JM, Montesinos M et al. Factors involved in the loss of bone mineral density after renal transplantation. Trans Proc 1995; 27: 2224-2225.
28. Campistol JM, Holt DW, Epstein S et al. Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus. Transpl Int 2005; 18: 1028-1035.
29. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501.
30. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004; 291: 1999-2006.
31. Sambrook PN, Chen JS, March LM et al. Serum parathyroid hormone predicts time to fall independent of vitaminD status in a frail elderly population. J Clin Endocrinol Metab 2004; 89: 1572-1576.
32. Pasco JA, Henry MJ, Kotowicz MA et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 2004; 19: 752-758.
33. Pietschmann P, Vychytil A, Woloszczuk W et al. Bone metabolism in patients with functioning kidney grafts: increased serum levels of osteocalcin and parathyroid hormone despite normalisation of kidney function. Nephron 1991; 59: 533-536.
34. Compston JE, Greer S, Skingle SJ et al. Early increase in plasma parathyroid hormone levels following liver transplantation. J Hepatol 1996; 25: 715-718.
35. Giannini S, D'Angelo A, Carraro G et al. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation. Clin Nephrol 2001; 56: 353-363.
36. Wada C, Kataoka M, Seto H et al. High-turnover osteoporosis is induced by cyclosporin A in rats. J Bone Miner Metab 2006; 24: 199-205.
37. Nozue T, Kobayashi A, Sako A et al. Evidence that cyclosporine causes both intracellular migration and inaproppriate urinary excretion of magnesium in rats. Transplantation 1993; 55: 346-349.
38. Aicher L, Meier G, Norcross AJ et al. Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporineA- and FK-506-induced calciuria and tubular mineralization. Biochem Pharmacol 1997; 53: 723-731.
39. 28K expression by cyclosporinA in rat kidney: the possible pathogenesis of cyclosporinA-induced hypercalciuria. J Am Soc Nephrol 1998; 9: 1416-1426.
40. Aicher L, Meier G, Norcross AJ et al. Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A and FK-506-induced calciuria and tubular mineralization. Biochem Pharmacol 1997; 53: 1945.
41. DeBoer DJ, Hillier A. The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Vet Immunol Immunopathol 2001; 81: 271-276.
42. Bennett SL, Abraham LA, Anderson GA et al. Reference limits for urinary fractional excretion of electrolytes in adult non-racing Greyhound dogs. Aust Vet J 2006; 84: 393-397.
43. Mawer EB, Hann JT, Berry JL et al. Vitamin D metabolism in patients intoxicated with ergocalciferol. Clin Sci (Lond) 1985; 68: 135-141.
44. Mawer EB, Berry JL, Cundall JP et al. A sensitive radioimmunoassay using a monoclonal antibody that is equipotent for ercalcitriol and calcitriol (1, 25-dihydroxy vitamin D2 and D3). Clin Chim Acta 1990; 190: 199-209.
45. Berry JL, Martin J, Mawer EB. 25-Hydroxyvitamin D assay kits: speed at the cost of accuracy? In: Norman AW, Bouillion R, Thomasset M, eds. Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects. Riverside, CA: University of California. 2000; 797-800.
46. Olivry T, Marsella R, Iwasaki T et al. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet Dermatol 2007; 18: 78-86.
47. Colombo S, Hill PB, Shaw DJ et al. Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: a prospective, double-blinded, clinical study. Vet Dermatol 2005; 16: 162-170.
48. Kovalik M, Thoday KL, Handel IG et al. CiclosporinA therapy is associated with disturbances in glucose metabolism in dogs with atopic dermatitis. Vet Dermatol 2011; 22: 173-180.
49. Epstein S, Dissanayake IR, Goodman GR et al. Effect of the interaction of parathyroid hormone and cyclosporineA on bone mineral metabolism in the rat. Calcif Tissue Int 2001; 68: 240-247.
50. Evenepoel P, Claes K, Kuypers D et al. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 2004; 19: 1281-1287.
51. Tsuruoka S, Kaneda T, Maeda A et al. Dosing time-dependent variation of bone resorption by cyclosporinA in rats' femurs. Eur J Pharmacol 2007; 564: 226-231.
52. Stewart AF, Broadus AE. The regulation of renal calcium excretion: an approach to hypercalciuria. Annu Rev Med 1981; 32: 457-473.
53. Gross M, Kumar R. Physiology and biochemistry of vitaminD-dependent calcium-binding proteins. Am J Physiol 1990; 259: F195-F209.
54. Christakos S, Gabrielides C, Rhoten WB. VitaminD-dependent calcium-binding proteins: chemistry, distribution, functional considerations, and molecular biology. Endocr Rev 1989; 10: 3-26.
55. 2+ fluxes in isolated hepatocytes. J Biol Chem 1985; 260: 3613-3618.
56. Gow AG, Gow DJ, Bell R et al. Calcium metabolism in eight dogs with hypoadrenocorticism. J Small Anim Pract 2009; 50: 426-430.